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ABSTRACT 
Purification and Characterization of a Chemically Induced 
Epstein-Barr Virus-Associated Deoxyribonuclease 
by 
Guang-Yuh Hwang, Master of Science 
Utah State University, 1989 
Major Professor: Joseph K.-K. Li 
Department : Biology 
vi 
Purification of Epstein-Barr virus-associated deoxyribonuclease (EBV-DNase) 
from Raji and P3HR-1 cells treated with 12-0-tetradecanoylphorbol-13-acetate and 
sodium butyrate was performed by sequential ion-exchange column chromatography and 
fast protein liquid chromatography. The enzyme activity, protein concentration, yield , 
specific activity, purification profiles, and polypeptide patterns by electrophoretic 
analysis in each column purification step were determined. The characteristics of the 
partially isolated EBV-DNase were demonstrated by the enzyme activity, DNA binding 
affinity, and inhibition by the nasopharyngeal carcinoma patient sera and rabbit 
polyclonal antibodies against the partially purified EBV-DNase. A nonisotopic assay was 
developed as a new method in detecting the nuclease. EBV-DNase was purified to 
homogeneity by FPLC. The molecular weight of the EBV-DNase was 58 KDa as 
determined by sodium dodecylsulfate polyacrylamide gel electrophoresis, 
immunostaining, and radioimmunoprecipitation using nasopharyngeal carcinoma patient 
sera and rabbit polyclonal antibodies. 
(46 pages) 
INTRODUCTION 
Epstein-Barr virus (EBV), a member of the human gamma-herpesvirus family, 
is a B-lymphocyte-transforming virus that causes infectious mononucleosis (IM) (15, 
30) . Furthermore, there is strong evidence that EBV, as a human carcinogenic agent, 
causes African Burkitt's lymphoma (BL) (13) and nasopharyngeal carcinoma (NPC) 
(22) within specific races of people. The association of EBV to these two cancers is 
supported by the evidence that EBV genomes are found in BL and NPC tumor tissues of 
infected patients (I 2) . These two types of cancer also have high malignancy and 
mortality rates as follows : BL is an endemic malignancy affecting mainly children in 
East Africa and New Guinea, while NPC is the most common malignancy in Southeast Asia. 
No specific reason has been found for the susceptibility of these populations, but it 
appears to involve both genetic and environmental factors (36). 
EBV, as do other herpesviruses , has a biological property of inducing latent and 
persistent infection to the mature 8-lymphocytes. The EBV target cells are mainly 
terminally differentiated cells that have receptors for complement binding and 
synthesize all of the different classes of the immunoglobulin heavy and light chains 
(33). The virus enters the host cell by fusion with the cell membrane. Viral DNA may 
be expressed or exist intracellularly in an unexpressed state known as latency that can 
be chemically activated to express. Upon activation by inducing agents, the viral DNA is 
transcribed and replicated in the nucleus, and the viral mRNAs are translated in the 
cytoplasm. The translation products then return to the nucleus where the nucleocapsid 
is assembled. The capsids acquire an envelope from the outer lamella of the nuclear 
membrane during assembly. The EBV viral antigens expressed during the latent and 
replicative cycles include the Epstein-Barr nuclear antigen (EBNA), lymphocyte-
determined membrane antigen (L YDMA), viral capsid antigen (VCA), membrane antigen 
(MA), and early antigens (EA). The EBNA is expressed in EBV-immortalized human 
2 
lymphocytes and, thus, may play an important role in immortalization (16) . The 
L YDMA, demonstrated using in Wl:Q tests of cell-mediated cytotoxicity, is distinguished 
from viral membrane antigens (MA) that are found on the surfaces of cells synthesizing 
virions and are also components of the virion envelope (34). The VCA is found within 
the cells which are producing viruses. Patients with NPC have high antibody titers to 
EBV-VCA. The major approach in the study of the epidemiology of EBV infections is 
detection of the antibody to EBV-VCA (17) . The MA, which is found on the cytoplasmic 
membranes of the cells that are producing virions, is also responsible for eliciting 
virus-neutralizing antibodies (1 0). Early antigens are a group of nonstructural 
components whose synthesis does not require viral DNA synthesis. They can be 
synthesized when an infected lymphoid cell is spontaneously triggered into viral 
replication or when the viral replicative cycle is induced by exogenous stimuli such as 
phorbol esters or sodium butyrate (SB) . The functions of the proteins represented in 
the early antigen complex are still unknown but are likely associated with the enzymes 
that are required for viral DNA replication (31) . 
Three virus-encoded enzymes, including DNA polymerase (DP) (20), thymidine 
kinase (TK) (11), and deoxyribonuclease (DNase) (8), involved in viral replication 
have been identified. The presence of serum antibody of the lgA type to EBV-VCA is the 
basis of a screening test for the detection of NPC. However, it is not sensitive enough to 
detect the early EBV infection. Patients with BL, IM, and NPC have elevated levels of 
entibody to early antigens, which appears to be evidence of ongoing viral infection . 
High-titer antibodies to the EBV-DNase have been detected and proved to be a sensitive 
epproach for the medical diagnosis of the early detection of EBV infections (4, 5). 
Although the complete genome of EBV has been cloned and sequenced, the 
ralationship between the viral products and their respective genes is still unknown 
(18). In order to unravel the mystery of EBV latency and its induction, a more detailed 
understanding of the viral enzymes involved in DNA replication is required. The 
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characterization and identification of the chemically induced EBV-associated DNase have 
been partially determined with respect to substrate specificity, strong divalent cation 
requirement (Mg2+), alkaline pH optimum {pH 8.3), and high salt resistance (8, 35, 
9, 6) . However, EBV-DNase has not been purified to homogeneity. Thus, reports on 
the determination of the molecular weight (M .W.) of the EBV-DNase are quite 
controversial (see Table t ). This conflict may be caused by the differential production 
of EBV-DNase(s) induced in different cell lines (20, 8, 32) or by the presence of an 
EBV-DNase-associated protein, such as EBV-DNA polymerase (7). 























Clough , 1979. 
( 8) 
Tan et al. , 1982. 
(35) 
Ooka et al., 1984. 
(32) 
Kallin et al., 1985. 
( 2 0) 
a Principal peptide bands of 60 KDa and 120 KDa were present, as well as several 
bands of lower molecular weights in the range of 30 KDa. 
6 TPA stands for 12-0-1etradecanoylphorbol-13-acetate and SB stands for sodium 
butyrate . 
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Procedures to purify EBV-DNase by sequential column chromatography have 
been described (8, 35, 9). Because of difficulties in propagating EBV in large amounts, 
as well as poor recovery and the instability of EBV-DNase, it is necessary to induce 
very large numbers of cells in order to obtain sufficient amounts of enzyme for 
purification. Raji and P3HR-1 (see Table 2) cells that are latently infected with EBV 
exhibit increased expression of EBV-DNase activity when treated with TPA (37) and SB 
(32). TPA is a diterpene ester, known as a tumor-promoting agent that induces the 
gene expression of oncogenic herpes viruses in persistently infected cells (38). SB is a 
differentiation inducer that has been found to increase the number of virus-producer 
cells to a dramatic extent in the EBV-carrying cell lines (25). 




African Burkitt's lymphoma 
(EBV-nonproducer) 
African Burkitt's lymphoma 
(EBV-producer) 
% cell stained specifically for 







a The data was adapted from Zur Hausen et al., 1978 (38). 
b The cells were stained with a human EA+ VCA+ serum (1 :40 dilution) 5 days 
alter the addition of 20 ng/ml of TPA. 
The frequency and levels of antibody against EBV-DNase in NPC-patient sera are 
much higher than in sera of healthy individuals or individuals with IM or BL. Thus, 
use of purified EBV-DNase may aid in the early diagnosis of NPC. Furthermore, the 
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identification of the M.W. and amino acid sequence of purified EBV-DNase will be useful 
in the determination of the viral coding region as well as the molecular aspects of EBV. 
Therefore, the objectives of this thesis were to purify the chemically induced 
EBV-DNase to homogeneity, to determ ine its M.W .• to investigate some of the 
biochemical characteristics of the purified EBV-DNase. and to produce polyclonal anti-
EBV-DNase sera for immunological determinations and subsequent experimentation . 
6 
MATERIALS AND METHODS 
Chemical induction in Raji and P3HR-1 cell lines. Lymphocyte cell 
lines have been previously described (14) . Raji (a Burkitt's tumor nonproducer B-cell 
line) and P3HR-1 (a Burkitt's lymphoma-derived cell line) cells were maintained 
between 5 x 105 to 1 x 106 cells/ml in RPMI-1640 (GIBCO, Grand island, NY) medium 
containing 10% heat-inactivated fetal calf serum (Hyclone, Logan, UT). Raji and 
P3HR-1 cells were seeded at 106 cells per ml in culture medium. TPA (Sigma, St. 
Louis, MO) was added at a final concentration of 40 ng/ml. SB was added at a final 
concentration of 4 mM. The culture was incubated at 37<lC for 64 -72 hrs. 
Preparation of Escherlchja ~ [lHJ-DNA. Native double-stranded L 
kQ}1 [3H]-DNA was prepared from the thymine-requiring strain. The bacteria were 
grown in 2 liters of a minimal medium containing 40 mM K2HP04, 22 mM KH2P04, 2 
mM Na3C6H507, 0.4 mM MgS04.H20, 7 mM (NH4)2S04, 0.25% glucose (w/v), 2.5 
11M unlabelled thymine, and 500 11Ci of 3H-thymine (NEN, Boston, MA). [3H]-DNA 
was isolated by the procedure of Marmur (26) . Isolated £. !<QJ1 [3H]-DNA was used as 
substrate in EBV-DNase enzyme activity assays. 
EBV-DNase assay. EBV-specific DNase enzyme activity was measured by the 
release of acid-soluble nucleotides from double-stranded [3H]-DNA by the method of 
Hoffman and Cheng (18). Briefly, each reaction solution contained 0.2 ml of 50 mM 
Tris (pH 8.3), 10 mM MgCI2, 10 mM 13-mercaptoethanol, and 1.2 11g of £!<Qfi [3H]-
DNA. The enzyme assay mixture contained 10 111 of enzyme preparation plus 190 111 of 
the reaction solution. The assay was incubated at 37°C for 40 min with constant 
shaking. Following incubation, calf thymus DNA (Sigma, St. Louis, MO) was added as a 
carrier to a final concentration of 0.25 11g per mi. Trichloroacetic acid (TCA) 
(Mallinockrodt, Paris, KY) was added to a final concentration of 5% in each assay to 
7 
precipitate the undigested DNA substrate. Each reaction tube was kept in ice for 20 min. 
Following centrifugation at 3,000 rpm for 10 min (SAVANT, model PH40-11, 
Hicksville, NY). 200 ~I of the acid-soluble nucleotide was removed from the 
supernatant for scintillation counting in a Beckman LS-7800 liquid scintillation 
counter . .E. {;Q}1 DNase I was used as a positive control in this assay. 
Purification of the chemically induced EBV-DNase. The procedures of 
Goodman et al., 1978 (14) for harvesting the cells, making the crude cell extracts, and 
performing DEAE-cellulose, phosphocellulose, and DNA-ce llulose column 
chromatography were followed with minor modifications: The cell extracts from 10 
liters of Raji cells were centrifuged at 12,000 x g for 20 min in a SS-34 rotor in a 
Sorvall RC-2B centrifuge, and the resulting supernatant was loaded onto a DEAE-1-
cellulose column (2 x 5 em) that was equilibrated and eluted with 300 mM potassium 
phosphate buffer (pH 8.3) containing 20% glycerol (v/v), 1 mM 
phenylmethanesulfonylfluoride (PMSF) (Sigma, St. Louis, MO) , 1 mM EDTA, and 2 mM 
dithiothreitol (OTT) (Boehringer Mannheim, Kuhl Lagern, W. Germany) . The eluted 
samples in the peak fractions were pooled, dialysed against 20 mM potassium phosphate 
buffer (pH 8.3) at 4oc, and centrifuged at 12,000 x g for 20 min (Sorvall, SS-34 
rotor). The dialysate was loaded onto another DEAE-11-cellulose column (2 x 5 em). 
The EBV-DNase was eluted with a linear gradient of 50-300 mM potassium phosphate 
buffer (pH 8.3). Fractions of 3 ml from the DEAE-11-cellulose column were collected 
and assayed. Fractions containing DNase activity were pooled and dialysed against 1 liter 
of 20 mM potassium phosphate buffer (pH 8.3) for 15 hrs at 4oc . Dialysed DEAE-11-
cell ulose DNase peak fractions were loaded onto a phosphocellulose column (1 .5 x 5 em). 
A gradient elution from 50 to 300 mM potassium phosphate buller {pH 8.3) was used. 
Fractions of 2 ml were collected and the enzyme activity was determined. The fractions 
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containing the EBV-DNase were pooled and dialysed against 1 liter of 20 mM potassium 
phosphate buffer (pH 8.3) for 15 hrs at 4oc . 
Dialysed phosphocellulose DNase peak fractions were loaded onto a DNA-cellulose 
column (1 .2 x 1 em) . A gradient elution of 50 to 400 mM potassium phosphate buffer 
(pH 8.3) was used. Fractions of 1 ml were collected and the enzyme activity was 
determined. The fractions containing the EBV-DNase were pooled and dialysed against 1 
liter of dialysis buffer (20mM Tris-buffer (pH 8.3) , 40% glycerol (v/v) , 2 mM DTT, 
2 mM PMSF) at 4oc ovenight. The dialysed EBV-DNase was stored at -7ooc until used. 
EBV-DNase neutralization assay. Neutralization of EBV-DNase activity by 
human NPC sera (provided by Dr. J . F. Chiou , Taipei, and Dr. R. S. Tan, Beijing) and 
rabbit polyclonal was assayed as described by Cheng et al. (5) . After incubation at room 
temperature for 20 min , the immunocomplexes were pelleted by centrifugation at 
3,000 rpm for 10 min in a swinging bucket rotor (SAVANT, model PH40-11 , 
Hicksville, NY), and the supernatant was examined for DNase enzyme activity( described 
above) . 
SDS-PAGE, blotting , and immunostaining. Sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) was carried out according to Laemmli 
(23) using 1 0% gels. After electrophoresis, gels were silver stained by the method of 
Merril et al. (29). Proteins were transferred to nitrocellulose paper by the method of 
Bowen et al. (3) . lmmunostaining of proteins on nitrocellulose paper was carried out 
according to Legocki and Verma (24) by using alkaline phosphatase-conjugated goat 
antibodies (2) . 
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EBV-DNase determination by agarose gel electrophoretic analysis. 
Specific EBV-DNase nucleolytic reactions were carried out as described in the EBV-
DNase assay. The reaction solution contained 50 iJ.I of 50 mM Tris (pH 8.3), 1 0 mM 
MgCI2, 10 mM B-mercaptoethanol, 2 IJ.g of the BstE n-digested Lambda-DNA (Biolabs, 
Beverly, MA} , and 4 IJ.g of the partially purified EBV-DNase. The mixture was incubated 
in the presence and absence of NPC patient sera in a 37<>C water bath with constant 
shaking . Five microliters (iJ.I) of the reaction mixture containing 0.2 llg of BstE n-
digested Lambda-DNA was removed at different time intervals and was put into a pre-
cooled microcentrifuge tube for agarose gel electrophoretic analysis. The BstE 11-
digested Lambda-DNA was analysed in 1% horizontal agarose gel in TBE buffer (89 mM 
Tris-borate, 89 mM boric acid, 2 mM EDTA, 0.5 llg of ethidium bromide per ml, pH 
8.0) (28) . .1;.,.~ DNase I was used as a positive control, and BstE II·digested Lambda-
DNA in the absence of enzyme preparation was used as a negative control. 
Gel-retardation analysis of the DNA-cellulose peak fraction B. The 
DNA-binding affinity of the partially purified EBV-DNase was determined in 
polyacrylamide gel electrophoresis (PAGE) . The DNA-cellulose peak fraction was used 
as enzyme to digest Hind III-digested Lambda-DNA (Biolabs, Beverly, MA) . DNA binding 
was performed at 4oc in the absence of Mg2+ , which is the required cation in this 
nucleolytic reaction. The reaction solution contained 50 iJ.I of 50 mM Tris (pH 8.3), 10 
mM B-mercaptoethanol, 0.2 llg of the Hind III-digested Lambda-DNA, and 8 IJ.g of the 
partially purified EBV-DNase. The mixture was analysed by the PAGE at 4oc followed 
by 40 min of nucleolytic reaction. The same amount of the EBV-DNase in the absence of 
Hind III-digested Lambda-DNA was used as negative control. 
Radioiodination of the DNA-cellulose peak fraction B. The 
chloramine-T procedure was used for radioiodination of proteins (19). The iodination 
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was carried out at room temperature. DNA-cellulose samples were incubated with 0.5 
mCi of Na125J (ICN, Costa Mesa, CA) and 160 !lg of chloramine-T (Sigma, St. Louis, 
MO) in 400 !11 of 50 mM potassium phosphate buffer, pH 8.3. Glycine was added to a 
final concentration of 15 !lgiml after a 1 min of iodination period to prevent any 
subsequent iodination. Separation of labelled EBV-DNase from unincorporated label was 
carried out by gel filtration using a column containing 30 mg of 48 dextran (Bio-Rad, 
Richmond, CA). Precipitation of iodinated EBV-DNase was done by mixing the labelled 
EBV-DNase with TCA to a final concentration of 10% at 4°C overnight. 
Production of rabbit polyclonal antibodies. The partially purified EBV-
DNase from the DNA-cellulose peak fractions (300 !lg) was used for immunization to 
produce rabbit antiserum to the EBV-DNase. The rabbit was immunized by repeated 
intradermal injection . The first inoculum consisted of 0.25 ml of complete Freund 
adjuvant mixed with 0.25 ml of the antigen preparation (1 00 !lg) . The animal was 
boosted with incomplete Freund adjuvant once a month and bled from the ear 1 week 
after each booster. Pre-immuned serum was collected from the rabbit 1 week before 
immunization began. Sera from the injected rabbit were tested by dot immunostaining 
with partially purified EBV-DNase as antigen and screened for neutralization antibodies 
to the viral DNase by a neutralization assay. 
Radioimmunoprecipitation (RIP). The iodinated DNA-cellulose peak 
fraction B was pre-absorbed by the EBV-negative human serum (provided by NIH) or 
pre-immuned rabbit serum before immunoprecipitation . The pre-absorbed 
supernatants were assayed for nuclease activity. lmmunoprecipitations were carried 
out for 18 hrs at 4oc by using rabbit anti -DNase sera and human NPC sera. The 
resulting complexes were precipitated by the addition of protein A-sepharose (Sigma, 
1 1 
St. Louis, MO), followed by incubation at 4oc for 30 min with constant shaking. 
Protein A-sepharose and adhering immune complexes were collected by centrifugation 
and then washed 6 times in phosphate buffer saline (PBS), pH 7.3. Protein A-sepharose 
was separated from immune complex by boiling for 1 0 min in SDS-PAGE sample buller 
(50 mM Tris, pH 7.3, 1% SDS (w/v), 20% glycerol (v/v), 5% B-mercaptoethanol 
(v/v) , and 100 11giml of Bromphenol Blue) . The protein A-sepharose was then 
pelleted, and the supernatant was removed and analysed by SDS-PAGE and 
autoradiography. The dried gel was exposed to Kodak X-AR film at -2ooc . 
FPLC purification of DNA-cellulose peak fraction B. Partially 
purified EBV-DNase from the peak fraction of the DNA-cellulose column was further 
fractionated by a Mono a (HR 5/5) column using a Pharmacia high-resolution FPLC 
system (21). The Mono a column was equilibrated with 10 mM sodium acetate buller, 
pH 6.0, and a total of 40 119 of protein was loaded onto the column. The column was 
washed with 10 mM sodium acetate buller, pH 6.0, and proteins were eluted with a 
linear gradient containing 10-1000 mM sodium acetate buller, pH 6.0. The flow rate 
was 1 mVmin, and 1 ml fractions were collected. The nuclease activity of each fraction 
was determined and neutralization by human NPC sera was also assayed. The peak 
fractions with nuclease activity and neutralization activity were pooled, concentrated by 
TCA precipitation for three days, and then analysed by SDS-PAGE. 
1 2 
RESULTS 
Purification of the chemically Induced EBV-DNase in P3HR-1 and 
Raji cells. The combination of diterpene ester promoter of mouse skin tumors, TPA, 
and cell differentiation inducer, SB, was used to induce DNase activity in the Epstein-
Barr virus-producer cell line P3HR-1 (37} and the Burkitt's tumor nonproducer Raji 
cell line (32}. The chemically induced EBV-DNase from Raji cell lysates was partially 
purified by sequential ion-exchange column chromatography, and the profiles of each 
purification step are shown in Figs. 1, 2, and 3. Each peak fraction could be 
neutralized by human NPC sera. The chemically induced EBV-DNase in Raji cell extracts 
eluted from DEAE-n-cellulose at 125 mM (Fig . 1}. phosphocellulose at 225 mM (Fig. 
2}. and DNA-cellulose at 250 mM potassium phosphate buffer (Fig. 3} . Based upon 
these elution profiles and neutralization by human NPC sera, the chemically induced 
EBV-DNase is different from the cellular DNase (8, 35, 7} . 
In Tables 3 and 4 are summarized the total enzymatic activity, specific activity, 
yield, and purification in each of the column chromatographic steps. The specific 
enzyme activity of the partially purified DNase increased 70-fold over that of the crude 
extracts and represents a 5.4% recovery in induced-Raji cells (Table 3} and a 2.1% 
recovery from induced-P3HR-1 cells (Table 4) . 
The SDS-PAGE analysis of samples from different steps of EBV-DNase 
purification in Raji and P3 HR-1 cell lines was visualized by silver staining . The 
results are shown in Figs. 4 and 5. The DNA-cellulose samples purified from Raji cells 
contained five major bands with the M.W. of 50 kilodaltons (KDa}, 52 KDa, 58 KDa, 66 
KDa, and 80 KDa (Fig. 4}. However, the DNA-cellulose samples purified from P3HR-1 
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Fig. 1. DEAE-11-cellulose column chromatography purification profile of EBV-DNase 
from TPNSB-induced Raji cell extracts. The DNase activity was measured by 
the release of acid-soluble nucleotide from £. ~ [3H[-DNA. 
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Fig . 2. Phosphocellulose column chromatography purification profile of EBV-DNase . 
Fractions 4 through 6 from DEAE-11-cellulose were pooled, dialysed, and then 
chromatographed as described under Materials and Methods. The DNase activity 
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Fig . 3. DNA cellulose column chromatography purification profile of EBV-DNase. 
Fractions 10 through 12 from phosphocellulose were pooled, dialysed, and then 
chromatographed as described under Materials and Methods. Peak fractions A and C 
cannot be inhibited by human NPC sera. Peak fractions B can be inhibited by 
human NPC sera. Fractions B was used in all subsequent experiments. The DNase 
activity was measured by the release of acid-soluble nucleotide from £ kQJ1 [3H] -
DNA 
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Table 3 . Purification of EBV-DNase from TPN SB-induced Raji cells" 
Volume Total protein Total activity Specific activity Yield Purification 
(ml) (mg) (unit)& (unit/mg) (%) 
Crude extract 40.0 538.0 259 .8 0.48 100.0 1.0 
DEAE-Il 24 .0 34.5 240 .0 2.94 92 .3 6.1 
Phospho-
cellulose 7.2 3.6 65.6 18.20 25 .2 37 .9 
DNA-cellulose 1.0 0.4 14.1 35.25 5.4 73 .4 
« 10 liter of Raj i cells were induced by 40 ng/ml of TPA and 4 mM of SB for three 
days. 
b One unit of DNase activity was defined as that amount of activity which digests 1 Jlg of 
native DNA to acid-soluble nucleotide in 10 min at 370C. 
Table 4. Purification of EBV-DNase from TPNSB-induced P3HR-1 cells" 
Volume Total protein Total activi ty Specific activity Yield Purification 
(ml) (mg) (unit)& (unit/mg) (% ) 
Crude extract 30.0 522 .00 141 .10 0.27 100.0 1.0 
DEAE-11 23.0 28.75 121.90 4.24 86 .3 15.8 
Phospho-
cellulose 10.0 5.10 75.60 14.28 53 .5 54.9 
DNA-cellulose 0.5 0.17 2 .99 17.60 2.1 65.2 
« 10 liter of P3HR-1 cells were induced by 40 ng/ml of TPA and 4 mM of SB for two 
and half days. 
& One unit of DNase activity was defined as that amount of activity which digests 1 Jlg of 
native DNA to acid-soluble nucleotide in 10 min at 370C . 
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Fig . 4. SDS-PAGE of samples from the peak fractions of the three columns used in the 
purification of EBV-DNase from the Raji cell extracts. Lanes A through E are 
described as follows: DNA-cellulose (lane A), phosphocelllulose (lane B), DEAE-
ll-cellulose (lane C), cell extracts (lane D), and molecular weight standards 
(lane E). Lanes A through E were visualized by silver staining. Proteins from 
these peak fractions and cell extracts were used in immunoblots. Proteins from 
DNA-cellulose peak fraction B were used in all subsequent radioiodination and 
FPLC. 
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Fig. 5. SDS-PAGE of samples from the peak fractions of the three columns used in the 
purification of EBV-DNase from the P3HR-1 cell extracts. Lanes A through Fare 
described as follows: molecular weight standard (lane A). cell extracts (lane B). 
DEAE-II-cellulose (lane C). phosphocellulose (lane D) , and DNA-cellulose (lanes 
E and F). Lanes A through F were visualized by silver staining. 
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Characterization of the chemically induced EBV-ONase. It has been 
observed that human NPC sera neutralized up to 86% of the EBV-DNase activity in 
partially purified samples (5) . The presence of EBV-DNase was verified by the results 
shown in Table 5. The DNase activity was neutralized up to 90% by human NPC sera and 
54% by rabbit polyclonal antibodies when compared with normal human sera and pre-
immuned serum. 
Considering the potential DNA affinity of EBV-DNase, a gel -retardation 
experiment was carried out in PAGE. The DNA-cellulose peak fraction B (Fig. 3) was 
mixed with Hind III-digested Lambda-DNA in test tubes at 4oc in the absence of MgCI2, 
the required divalent cation in this nucleolytic reaction (8). The large fragments of 
Hind Ill-digested Lambda-DNA were retarded at the stacking gel by binding with the EBV-
DNase in the DNA-cellulose samples. The results are shown in Fig. 6. After silver 
staining, proteins could not be visualized in the lane containing both Lambda-DNA and 
partially purified EBV-DNase ; however, proteins could be seen in the lane containing 
only partially purified EBV-DNase. These results indicate that the partially purified 
EBV-DNase has a DNA-binding affinity which causes non-visualized proteins at the 
running gel of PAGE. Moreover, in the absence of Mg2+, the nucleolytic reaction can not 
occur. 
The partially purified EBV-DNase digested both native and denatured DNA to 
mononucleotides (8). To determine whether restriction-enzyme-digested Lambda-DNA 
could be used as substrate, and if the reaction could be visualized by staining instead of 
the standard isotopic assay, the nuclease activity of EBV-DNase on BstE 11-digested 
Lambda-DNA and its neutralization by human NPC sera were investigated in agarose gel 
electrophoresis. The DNA-cellulose peak fraction B (Fig. 3) was used as enzyme to 
digest BstE 11-digested Lambda-DNA. The results are shown in Fig. 7. In lanes 2 to 5 of 
Fig .7 it is evident that partially purified EBV-DNase digested Lambda-DNA in 1% 
agarose gel in the different intervals. In lanes 6 to 14 it is evident that the nuclease 
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activity of the partially purified EBV-DNase could be neutralized by the addition of 
human NPC sera prior to the commencement of the 40 min nucleolytic reaction . These 
results indicate that the partially purified EBV-DNase could digest Lambda-DNA. Human 
NPC sera could neutralize the nuclease activity completely. DNA digestion required 
Mg2+ and the nonisotopic assay could be easily visualized. 
Table 5. lnhibitiona of EBV-DNase by 1 :20 dilution of human NPC sera and rabbit 
polyclonal antisera 
Non·induced cell lysate Crude extracts Purified EBV -DNase 
-------------------------------------------------------------
Enzyme activity& 340" 1807 4196 
(no serum) 
Normal sera 349 (N)d: 2010 (N) 3580±.267 (14) 
Human NPC sera 204 (40) 408 (77) 422±.23 (90) 
Enzyme activity 340 1583 3204 
(no serum) 
Pre-immuned sera 253 (0) 1721 (N) 3090±.31 (4) 
Rabbit antisera 234 (31) 641 (60) 1483±.196 (54) 
a Inhibition was defined as that amount of decreased activity of EBV-DNase in the 
presence of each corresponding antibody. 
b Nuclease activity assays were performed as described under Materials and Methods. 
c Radioactivity in cpm as determined by scintillation counting. 
<L Values in parentheses represent % of inhibition, and N in parentheses represent no 
inhibition. 
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Fig. 6. Determination of the DNA-binding affinity and the Mg2+ requirement of the 
partially purified EBV-DNase in a 12.5% PAGE. Molecular weight standards 
(lane A), DNA-cellulose peak fraction B mixed with Hind III-digested Lambda-
DNA in the absence of the divalent cation (Mg2+) at 4oc (lane B). DNA-cellulose 
peak fraction B (lane C), and Hind III-digested Lambda-DNA (lane D). 
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Fig.?. Determination of the partially purified EBV-DNase activity in a 1% agarose gel. 
Each lane contains 0.2 11g of BstE 11-digested Lambda-DNA. Lanes 1 through 15 are 
described as follows: 
BstE 11-digested Lambda-DNA which has 14 fragments with different sizes (lane 
1 ), BstE n-digested Lambda-DNA digested by EBV-DNase for 20, 40, 60, and 80 
min (lanes 2 to 5, respectively ), BstE 11-digested Lambda-DNA digested by EBV-
DNase for 20, 40, 60, and 80 min of a nucleolytic reaction to which a 1/20 
dilution of human NPC sera had been added (lanes 6 to 9, respectively ), different 
dilutions (1/1 0, 1/20, 1/40, 1/60, 1/80) of human NPC sera were added 
prior to a 40 min nucleolytic reaction (lanes 10 to 14, respectively ), and BstE 
IJ-digested Lambda-DNA by£. coli DNase I (lane 15). 
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Determination of the M.W. of the chemically induced EBV-DNase. 
Due to the low concentration of protein in the column eluants, the volumes of the peak 
fractions were reduced prior to protein analysis by SDS-PAGE. Despite these efforts, 
the concentrated nuclease-active fraction from DNA-cellulose chromatography produced 
only a faint protein banding pattern in SDS-PAGE. The results are shown in Figs. 4 and 
5. However, the M.W. of chemically induced EBV-DNase has been reported (20 , 8, 32) 
with a M.W. ranging between 70 KDa and 58 KDa (see Table 1). 
Three methods were used to determine the M.W. of the chemically induced EBV-
DNase from TPNSB-induced Raj i cells . They were immunostaining, radioimmuno-
precipitation (RIP), and the ion-exchange chromatography using FPLC. The 
immunostaining data are shown in the western blots using human NPC sera (Fig. 8) and 
rabbit polyclonal antibodies (Fig . 9) . The results show a different reaction of human 
NPC sera and rabbit antisera to the antigen mixtures of different stages of purification. 
The human NPC sera showed broad reactions to the antigens in the range of 45 KDa and 
66 KDa. The rabbit antiserum showed a strong reaction to 58 KDa and 52 KDa proteins, 
even in the DNA-cellulose sample. 
The small amount of EBV-DNase could not be detected in western blots (Fig. 8, 
lane A) . Radioimmunoprecipitation was applied for enhancing the sensitivity in 
detecting the EBV-DNase. Equal amounts of DNA-cellulose samples were iodinated and 
then immunoprecipitated with the human EBV-negative sera , human NPC sera, pre-
immuned rabbit sera, and the rabbit polyclonal antisera. The resulting complexes were 
analysed by SDS-PAGE. An autoradiogram is shown in Fig. 10. To further reduce the 
non-specific background, iodinated samples were pre-absorbed with the human EBV-
negative sera or pre-immuned rabbit sera, and the pre-absorbed supernatants were 
then immunoprecipitated by human NPC sera or rabbit polyclonal antiserum. The 
results are shown in Fig. 11 . 
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The third approach to determine the M.W. of the EBV-associated DNase was to 
further purify this enzyme to homogeneity by FPLC. FPLC purification profile is shown 
in Fig. 14. Both FPLC peak fraction A and B had a nuclease activity, but only peak A was 
neutralizable by human NPC sera (Table 6). The specific activity of the peak-A fraction 
was 185 units/mg and a purification of 385-fold was achieved, but the yield was only 
1.7% (Table 7). SDS-PAGE analysis of FPLC peak fraction A and B is shown in Fig.13. 
The results showed that a small amount of the chemically induced EBV-associated DNase 
that could be neutralized by human NPC sera was purified to the homogeneity, as 
determined by silver staining (Fig.13, lane A) and had a M.W. of 58 KDa. The two 
proteins with M.W. of 58 KDa and 52 KDa present in fraction B (Fig .13, lane D) also 
had nuclease activity that was not neutralized by human NPC sera (Table 6). These 
results indicate the potential presence of two different DNases in the TPA/SB-induced 
Raji cell extracts. 
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Fig. 8. Western immunoblot of polypeptides from the peak fractions of the three columns 
and TPNSB-induced Raji cell extracts bound with human NPC sera at 1:100 
diluton in TBST buffer. DNA-cellulose peak fraction B (lane A). 
phosphocellulose (lane B), DEAE-II-cellulose (lane C), and cell extracts (lane 
D) were immunostained by alkaline phosphatase-conjugated goat anti-human 
lgG. Molecular weight standards (lane E) and 58 KDa pre-stained protein 
marker (pyruvate kinase from chicken muscle ) (lane F) were stained by 
Amido Black staining. 
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Fig. 9. Western immunoblot of polypeptides from the peak fractions of the three columns 
and TPAJSB-induced Raji cell extracts bound with rabbit polyclonal antisera at 
1:1 DO diluton in TBST buffer. Cell extracts (lane A), DEAE·Il-cellulose (lane 
B), phosphocellulose (lane C), and DNA-cellulose peak fraction B (lane D) were 
immunostained by alkaline phosphatase-conjugated goat anti-rabbit lgG. 58 
KDa pre-stained protein marker (lane E) and molecular weight standards (lane 
F) were stained by Amido Black. 
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Fig . 10. Autoradiogram of radioimmunoprecipitations of the iodinated EBV-DNase from 
the DNA-cellulose peak fraction by 1 :20 dilution of each of the corresponding 
antibodies: EBV-negative human sera (lane A). human NPC sera (lane B), pre-
immuned rabbit sera (lane C), and rabbit polyclonal antisera (lane D). The 
adhering immune complexes were pelleted by protein A-sepharose and analysed 
by 10% SDS-PAGE as described under Materials and Methods. 
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Fig. 11. Autoradiogram of radioimmunoprecipitations of the iodinated EBV-DNase from 
the DNA-cellulose peak fraction 8 by 1 :20 dilution of human NPC sera (lane A) 
and rabbit polyclonal antisera (lane B) . The iodinated DNA-cellulose peak 
fraction 8 was pre-absorbed by the human EBV-negative sera or pre-immuned 
rabbit sera. The adhering immune complexes were pelleted by protein A-
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Fig . 12. FPLC Mono Q column chromatography of the DNA-cellulose peak fraction B. The 
DNA-cellulose peak fraction B containing high nuclease activity and 
neutralizable activity by human NPC sera were run through a Mono Q column 
equilibrated in 10 mM sodium acetate buffer (pH 6.0) and eluted with a 10 to 
1000 m M sodium acetate linear gradient. Poo led peak fractions were 
precipitated in 15% TCA for 3 days at 4oc and then analysed by SDS-PAGE. 
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Table 6. Inhibition" of EBV-DNase from FPLC fractions by 1:20 dilution of human NPC 
sera 
Fraction no. 9 1 0 A B 
DNase activity& 81 7c ±.8 1 507±.334 4158±.282 1498±.73 
NPC sera added 517 429 621±.295 (85}<! 2437±.154 (N} 
a Inhibition is defined as that amount of decreased activity of EBV-DNase in the presence 
of 1 :20 dilution of human NPC sera. 
b Nuclease activity assays were performed as described under Materials and Methods. 
c Radioactivity in cpm as determined by scintillation counting. 
d: Values in parenthesis represent % of inhibition, and N in parenthesis represent no 
inhibition. 
Table 7. Purification of EBV-DNase from DNA-cellulose peak B fraction by FPLC 
Volume Total protein Total activity Specific activity Yield Purification 
(ml) (mg) (unit)" (unit/mg) (%) 
Crude extract 40 .0 538.0 259 .8 0.48 100 .0 1 . 0 
DNA-cellulose 1.0 0 .4 14 . 1 35 .25 5 .4 73 .4 
FPLcb 2.0 0 .0244 4.5 185.25 1.7 385 . 9 
a One unit of DNase activity is defined as that amount of activity which digests 1 11g of 
native DNA to acid-soluble nucleotide in 10 min at 370C. 
b Peak fraction 8 containing 40 llQ of partially purified EBV-DNase was loaded onto a 
Mono Q (HR 5/5} column . 
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Fig.13. SDS-PAGE of samples from FPLC peak fractions. Lanes A through D were 
visualized by silver staining. 
Lane A: peak A fraction of Mono Q column . 
Lane B: Molecular weight standards. 
Lane C: 58 KDa protein marker. 
Lane D: peak B fraction of Mono Q column. 
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DISCUSSION 
The data presented in this thesis show that an EBV-DNase can be chemically 
induced by TPNSB in Raji and P3HR-1 cell lines. Induced cells exhibit increased 
expression of the EBV-associated DNase as compared with the non-induced Raji cells and 
P3HR-1 cells. When the chemically induced Raji and P3HR-1 cells express EBV-DNase 
activity, this is an indication that the cells are undergoing active EBV DNA replication 
after latency activation . Ooka et al. demonstrated that the chemically induced DNase 
activity in Raji cells can be neutralized by the EBV-positive sera, mainly by sera from 
NPC patients (32). The chemically induced EBV-DNase activity was shown to be 90% 
neutralizable with human NPC sera but not with EBV-negative human sera. 
Furthermore, the rabbit antisera can also partially inhibit 54% of the EBV-DNase 
activity with the same property as human NPC serum does (Table 5). 
The partial purification of the chemically induced EBV-associated DNase from the 
cell extracts was accomplished by sequential ion-exchange column chromatography. The 
viral nuclease activity from Raji cell extracts eluted from DEAE-n-cellulose at low salt 
concentration, and from phosphocellulose and DNA-cellulose at high salt concentration 
(Figs. 1, 2, 3). These results are similar to those reported by Clough (9). After 
DEAE-cellulose, phosphocellulose, and finally DNA-cellulose chromatography, the 
nuclease showed a net purification of about 70-fold in both cell lines. The yield was 
about 5.4% of the total EBV-induced enzyme in the Raji crude extracts but only 2.1% 
from P3HR-1 cell lysate (Tables 3, 4). 
The chemically induced EBV-DNase, like those induced by herpes simplex virus 
types 1 and 2, has characteristics of an optimum alkaline pH, a strong requirement for 
Mg2+, and is unstable when highly purified (18) . Clough demonstrated that the EBV-
DNase isolated from P3HR-1 cells utilizes both single- and double-stranded DNA as 
template, reducing both to monophosphonucleotides (8). All of these characteristics 
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were confirmed by the investigation of the partially purified EBV-DNase from both 
TPNSB-induced Raji and P3HR-1 cells . 
The partially purified EBV-DNase exhibits a DNA-binding affinity as shown in a 
gel retardation analysis (Fig . 6). These data also confirm that the requirement of the 
divalent cation (Mg2+) is important in its nucleolytic reaction . Furthermore, the 
partially purified EBV-DNase can use the BstE 11 -digested Lamda-DNA as substrate for 
digestion, and the nuclease activity can be completely neutralized by human NPC sera 
(Fig . 7). The kinetics of digestion by EBV-DNase can be visualized by simple staining, 
and this nonisotopic assay provides an alternative method for the standard isotopic assay 
for EBV-DNase determination . 
The partially purified EBV-DNase is different from the cellular DNase based 
upon elution profile, optimum alkaline pH (pH 8.3), divalent cation requirement, 
substrate specificity, and neutralization by sera from NPC patients (8, 35, 7). Due to 
the limited recovery and stability of partially purified sample, the M.W. of EBV-DNase 
has not been determined accurately. However, the partially purified EBV-DNase has 
been reported to have a sedimentation coefficient of about 4S (Svedberg unit) (9, 32). 
A globular protein of this sedimentation coefficient value would have a M.W. of 
approximately 58 KDa (27). SDS-PAGE analysis of EBV-DNase purified from Raji and 
P3HR-1 cell lines showed two similar polypeptides, 58 KDa and 52 KDa in the DNA-
cellulose peak fraction (Figs. 4, 5) . The M.W. of 58 KDa supports the assignment of the 
size of EBV-DNase with 4S. The 52 KDa protein can be either a second EBV-DNase or a 
host DNase contaminant. 
Studies from immunostaining of western blots show that (i) the anti-EBV DNase 
rabbit antisera strongly reacted with the 52 KDa and 58 KDa proteins of the DNA-
cellulose samples (Fig. 9), and (ii) the human NPC sera reacted with several proteins 
including the 58 KDa and 52 KDa proteins (Fig. 8). This information indicates that 58 
KDa and 52 KDa could be the M.W. of the chemically induced EBV-DNase. 
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Studies from radioimmunoprecipitation using rabbit anti-DNase sera , pre-
immuned rabbit sera, the EBV-negative, and EBV-positive human sera show that the 
rabbit antisera and human NPC sera precipitated a 58 KDa protein (Figs. 10, 11 ). 
There was no indication for specific precipitation of a protein with similar M.W. by the 
rabbit pre-immuned serum and human EBV-negative serum. These studies indicate that 
the chemically induced EBV-DNase has a M.W. of 58 KDa. 
EBV-DNase was also purified to apparent homogeneity by FPLC (Fig.13} , and a 
385-fold purification was achieved. The specific activity of the highly puried enzyme is 
185 units/mg. However, the final yield of this enzyme was only about 1.7% of the total 
EBV-DNase in the Raji cell extracts (Table 7) . Two nuclease activity peaks were 
identified in FPLC (Fig.12). Peak A had nuclease activity and was neutralizable by NPC 
patient sera. SDS-PAGE analysis of peak A had a single protein band with a M.W. of 58 
KDa (Table 6). Peak B appeared to contain two proteins, 58 KDa and 52 KDa, but the 
associated nuclease activity was not neutralizable by human NPC sera (Fig.13). 
suggesting the presence of a second EBV-DNase or representation of a co-purified host 
DNase contaminant . These studies strongly suggest that the chemically induced EBV-
DNase has a M.W. of 58 KDa. 
The chemically induced Raji and P3HR-1 cells exhibit increased EBV-DNase 
nuclease activity, but non-induced Raji and P3HR-1 cells do not show this increase. 
This partially purified EBV-DNase is neutralized by human NPC sera and rabbit 
polyclonal antibodies but can not be neutralized by EBV-negative human sera or pre-
immuned rabbit sera. The chemically induced EBV-DNase purified by sequential ion-
exchange column chromatography has the following characteristics: an optimum alkaline 
pH {pH 8.3} , a high salt resistance in EBV-DNase activity assay, and ability to use 
Lambda-DNA as substrate. By using three different approaches, which include 
immunostaining , radioimmunoprecipitation and FPLC, the M.W. of the chemically 
induced EBV-DNase has been determined to be 58 KDa. This 58 KDa protein that was 
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purified to homogeneity shown as a single protein species in SDS-PAGE analysis has the 
highest EBV-DNase activity and is inhibited by both polyclonal rabbit antisera and 
human NPC sera. In previous reports , the determination of the M.W. of EBV-DNase was 
based on enzyme samples which had not been purified to homogeneity (20, 8, 35, 32) . 
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